Elimination of gambiense human African trypanosomiasis as a public health problem in Republic of Guinea: Paving the way for zero transmission.

Publication date: Jul 01, 2026

The Republic of Guinea has faced an important challenge with human African trypanosomiasis (HAT), which was endemic over the last century. After initial control in the 1960s-1970s, HAT resurged in the 1990s along the Guinean coast, driven by economic and demographic pressures on the mangrove ecosystem. In response, the Guinean government established a national control program in 2002, focusing on medical mass screenings. In 2012, vector control using tiny targets was introduced in the East Boffa focus to reduce fly density and human-vector contact. However, the Ebola epidemic from 2013 to 2016 disrupted these efforts, leading to a reliance on passive screening. Resuming screenings in 2016-2017 revealed increased cases in all foci except the East Boffa area, where vector control had been effective. Vector control continued during the SARS-CoV2 pandemic and at the same time targeted door-to-door screenings were introduced to target high-risk individuals. Since 2018, around 30,000 at-risk individuals have been screened annually. These strategies reduced the total number of new cases below 1 per 10,000 inhabitants in endemic areas over the period 2019-2023, allowing to validate the elimination of HAT as a public health problem. The Guinean team and partners then focused on systematic spatial monitoring of patients and community engagement in vector control. The program also integrates control of other neglected tropical diseases and addresses new research questions, especially about anatomical and animal reservoirs for parasites. These efforts, combined with implementation of improved diagnostic tests and new oral treatments, through active involvement in multiple clinical trials and studies, now aim to interrupt HAT transmission by 2030.

Open Access PDF

Concepts Keywords
1990s Animals
African Disease Eradication
Annually Guinea
Trypanosomiasis Humans
Insect Vectors
Public Health
Trypanosoma brucei gambiense
Trypanosomiasis, African
Tsetse Flies

Semantics

Type Source Name
disease MESH African trypanosomiasis
pathway KEGG African trypanosomiasis
disease MESH neglected tropical diseases
disease MESH Dis
pathway REACTOME Reproduction
disease MESH Cte
drug DRUGBANK Iron
drug DRUGBANK Gold
disease MESH bed
disease MESH communicable diseases
disease MESH malaria
pathway KEGG Malaria
disease MESH AIDS
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease MESH non communicable diseases
disease MESH Covid 19
disease MESH infections
drug DRUGBANK Diethylstilbestrol
disease MESH des
disease MESH Cas
drug DRUGBANK Factor IX Complex (Human)
disease MESH PCC
disease MESH NTD
drug DRUGBANK Etoperidone
disease MESH included
disease MESH trypanosomiasis
drug DRUGBANK Fexinidazole
drug DRUGBANK Nifurtimox
drug DRUGBANK Eflornithine
disease MESH relapses
disease MESH traps
drug DRUGBANK Spinosad
disease MESH zoonoses
disease MESH plan
disease MESH leprosy
disease MESH Buruli ulcer
disease MESH mycetoma
disease MESH noma
disease MESH yaws
drug DRUGBANK Trestolone
disease MESH Cam
drug DRUGBANK Coenzyme M
drug DRUGBANK Cysteamine
disease MESH eco

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *